SCHEMBL7401147

SCHEMBL7401147

Cc1cc(OCCBr)ccc1Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.46
PPARD Q03181 4/20 0.46
PPARA Q07869 3/20 0.46
DRD2 P14416 2/20 0.46
DRD4 P21917 2/20 0.46
DRD3 P35462 2/20 0.46
LTA4H P09960 5/20 0.45
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PLA2G2A P14555 1/20 0.41
NTRK1 P04629 1/20 0.40
IGF1R P08069 1/20 0.40
FGFR1 P11362 1/20 0.40
NTRK2 Q16620 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10878365 0.84 ALDH1A1 (0.55) PPARGPPARDPPARADRD2DRD4
SCHEMBL6206320 0.82 FFAR4 (0.50) PPARGPPARDPPARANPC1MAPT
SCHEMBL7401205 0.81 LTA4H (0.45) PPARGPPARDPPARALTA4HNPC1
SCHEMBL10602950 0.79 LTA4H (0.50) LTA4HSMN1; SMN2NTRK1IGF1RFGFR1
SCHEMBL12795603 0.79 LTA4H (0.50) LTA4HSMN1; SMN2NTRK1IGF1RFGFR1
SCHEMBL10828206 0.77 L3MBTL1 (0.54) PPARGPPARDPPARADRD2DRD4
SCHEMBL2291508 0.77 LTA4H (0.64) PPARALTA4HPLA2G2A
SCHEMBL10828202 0.76 KDM4E (0.51) PPARGPPARDPPARALTA4HNPC1
SCHEMBL10828077 0.76 LTA4H (0.57) LTA4HSMN1; SMN2NTRK1IGF1RFGFR1
SCHEMBL3146478 0.76 DRD2 (0.51) PPARGPPARADRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed